Belinostat Resolves Skin Barrier Defects in Atopic Dermatitis by Targeting the Dysregulated miR-335:SOX6 Axis

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2020.02.007

Related search